| 1834 |
National Cancer Institute |
Html |
es |
Tratamiento del cáncer de células renales (PDQ®)–Versión para profesionales de salud |
Resumen de información revisada por expertos acerca del tratamiento del cáncer de células renales. |
| vena cava | 0.123516 |
| renal carcinoma | 0.159056 |
| Compton CC | 0.125724 |
| renal-cell carcinoma | 0.14068 |
| pazopanib versus sunitinib | 0.125846 |
| Sin embargo | 0.110933 |
| único tratamiento | 0.110403 |
| advanced renal | 0.148043 |
| 7th ed | 0.125599 |
| randomized phase | 0.121201 |
| pelvis renal | 0.120181 |
| Escudier B | 0.130262 |
| dekernion jb | 0.116071 |
| patients with advanced | 0.115714 |
| nefrectomÃa citorreductora | 0.116589 |
| determinados pacientes | 0.124987 |
| Kidney Cancer | 0.108755 |
| metastatic renal cell | 0.258997 |
| metastatic renal carcinoma | 0.150259 |
| meses vs | 0.112102 |
| nefrectomÃa contralateral | 0.112298 |
| with metastatic renal | 0.190502 |
| Urol Clin North | 0.118145 |
| patients with metastatic | 0.181521 |
| single-center experience with | 0.110273 |
|
| lymphokine-activated killer cells | 0.109085 |
| cell carcinoma with | 0.117134 |
| determinados pacientes sobrevivirán | 0.111069 |
| metastatic renal | 0.292754 |
| Cancer Staging Manual | 0.154868 |
| National Cancer Institute | 0.108824 |
| advanced or metastatic | 0.109154 |
| advanced renal-cell carcinoma | 0.125408 |
| vena renal | 0.12378 |
| New York | 0.121032 |
| renal cell cancer | 0.159738 |
| cell carcinoma invading | 0.114504 |
| Clin Oncol | 0.183599 |
| Clin North Am | 0.116365 |
| or metastatic renal | 0.109426 |
| with advanced renal | 0.117403 |
| Byrd DR | 0.123857 |
| metastatic renal-cell carcinoma | 0.127732 |
| Tomczak P | 0.112446 |
| renal cell carcinoma | 0.996231 |
| Renal Pelvis Cancer | 0.111495 |
| células renales | 0.815564 |
| compared with | 0.113419 |
| AJCC Cancer Staging | 0.157448 |
|
CLICK HERE |
| 1901 |
National Cancer Institute |
Html |
es |
Tratamiento del glioma de tronco encefálico infantil (PDQ®)–Versión para pacientes |
Resumen de información revisada por expertos acerca del tratamiento del glioma de tronco encefálico infantil. |
| siguientes procedimientos | 0.461896 |
| IRM periódicas | 0.425856 |
| posibles factores | 0.428641 |
| efectos secundarios meses | 0.538429 |
| encéfalo benignos | 0.484108 |
| pontino intrÃnseco difuso | 0.901206 |
| efectos tardÃos | 0.636065 |
| PDQ Efectos tardÃos | 0.495055 |
| National Cancer Institute | 0.428512 |
| sustancia llamada gadolinio | 0.454314 |
| siguientes riesgos | 0.420658 |
| llamada neurofibromatosis tipo | 0.456821 |
| Instituto Nacional | 0.447041 |
| cinasa braf | 0.631095 |
| presente sumario | 0.527425 |
| PDQ Tratamiento | 0.518077 |
|
| determinados cambios | 0.420201 |
| neurofibromatosis tipo | 0.564203 |
| nuevos tipos | 0.430533 |
| sistema nervioso central | 0.564289 |
| Physician Data Query | 0.500648 |
| proteÃna braf | 0.427497 |
| Aboutâ„¢ Brain Tumors | 0.435067 |
| tumor dipg | 0.504754 |
| siguientes enlaces | 0.422666 |
| encefálico infantil recién | 0.732248 |
| panel derecho | 0.429689 |
| cuidado paliativo | 0.460842 |
| siguientes sumarios | 0.465406 |
| largo tiempo | 0.418821 |
| siguientes trastornos | 0.430211 |
|
CLICK HERE |
| 3434 |
National Cancer Institute |
Html |
es |
Té y prevención de cáncer |
Hoja informativa que resume los resultados de estudios realizados sobre el té y la prevención del cáncer. Incluye información sobre los ingredientes del té y las consideraciones de seguridad sobre el consumo de esta bebida. |
| tea polyphenol levels | 0.306381 |
| Gynecological Cancer | 0.306129 |
| Zhang M | 0.301852 |
| té oolong | 0.345261 |
| lung cancer | 0.322075 |
| green tea extract | 0.319452 |
| case-control study | 0.308604 |
| British Journal | 0.30281 |
| Breast Cancer Research | 0.324861 |
| Human Nutrition | 0.301844 |
| verde activa enzimas | 0.302661 |
| Singapore Chinese Health | 0.30349 |
| tea polyphenol | 0.33584 |
| black tea consumption | 0.317861 |
| Inoue M | 0.303594 |
| green tea rapidly | 0.307366 |
| nested case-control study | 0.302496 |
| PubMed Abstract | 0.999235 |
| tea consumption | 0.35794 |
| Women’s Health Study | 0.302821 |
| green tea consumption | 0.326657 |
| International Journal | 0.309091 |
| Yang CS | 0.303196 |
| cohort study | 0.312904 |
| Chinese Health Study | 0.305698 |
|
| Hakim IA | 0.303206 |
| Drinking green | 0.302093 |
| té verdeConcentración | 0.313111 |
| Health Study | 0.306628 |
| dietary intake | 0.301921 |
| Ohsaki study | 0.302059 |
| Cancer Research | 0.340725 |
| Iwasaki M | 0.30184 |
| Shanghai Cohort Study | 0.302687 |
| prospective cohort study | 0.306347 |
| subsequent risk | 0.303163 |
| Clinical Nutrition | 0.305674 |
| breast cancer | 0.401322 |
| modestly reduces breast | 0.302193 |
| tea consumption with | 0.307242 |
| extract supplement | 0.301849 |
| Cancer Institute | 0.306085 |
| controlled study | 0.301969 |
| Clinical Cancer Research | 0.312026 |
| prospective study | 0.303895 |
| green tea polyphenols | 0.325122 |
| tea catechins after | 0.306288 |
| Netherlands Cohort Study | 0.306092 |
| té verde—500 mg | 0.313535 |
|
CLICK HERE |
| 3514 |
National Cancer Institute |
Html |
en |
What Are Clinical Trials? |
Information about the basics of cancer clinical trials. |
| new ways | 0.630193 |
| cancer cells | 0.475957 |
| lab | 0.434305 |
| current treatments | 0.466814 |
| life | 0.434324 |
| successful cancer treatments | 0.521796 |
| protocol | 0.451986 |
| myth | 0.41589 |
| past clinical trials | 0.525022 |
| clinical trials | 0.959728 |
| animals | 0.41616 |
| plan | 0.415114 |
| longer lives | 0.47341 |
| knowledge | 0.414644 |
| final step | 0.483148 |
| cancer care | 0.469342 |
| new treatment | 0.469236 |
| disease | 0.417585 |
| charge | 0.415053 |
|
| new treatments | 0.461251 |
| researchers | 0.43553 |
| NCI-Supported Clinical Trials | 0.532591 |
| future patients | 0.47375 |
| people | 0.521173 |
| long process | 0.483044 |
| quality | 0.434346 |
| doctor | 0.432193 |
| effects | 0.4317 |
| cancer clinical trials | 0.54508 |
| principal investigator | 0.542203 |
| doctors | 0.435633 |
| needs treatment | 0.4739 |
| stages | 0.415306 |
| cancer | 0.611137 |
| research studies | 0.485202 |
| information | 0.432449 |
| time | 0.415923 |
|
CLICK HERE |
| 3543 |
Administration for Children and Families |
Html |
en |
HHS extends comment period for proposed revisions to Head Start performance standards |
HHS’ Administration for Children and Families announced today an extension to the public comment period for the proposed revisions to the Head Start performance standards. The open comment period is being extended by 30 days past the original Aug. 18 deadline and will now close Sept. |
| feedback | 0.653075 |
| website | 0.623074 |
|
|
CLICK HERE |
| 3547 |
Administration for Children and Families |
Html |
en |
$108 million awarded to support family violence victims and service providers |
Family Violence Prevention and Services Act (FVPSA) formula grants totaling $108 million have been awarded by the U.S. Department of Health and Human Services Administration for Children and Families (ACF) to support state, territorial, and tribal domestic violence victims and organizations. |
| feedback | 0.653075 |
| website | 0.623074 |
|
|
CLICK HERE |
| 3657 |
Administration for Children and Families |
Html |
en |
ACF and IHS award $21 million to support Tribal family violence victims and organizations |
October marks National Domestic Violence Prevention Month and today, the U.S. Department of Health and Human Services Administration for Children and Families (ACF) and Indian Health Service (IHS) are announcing the award of nearly $21 million to support tribal domestic violence victims and organizations in American Indian and Alaska Native communities across the nation. |
| feedback | 0.653075 |
| website | 0.623074 |
|
|
CLICK HERE |
| 3660 |
Administration for Children and Families |
Html |
en |
Health Profession Opportunity Grants Awarded |
The HPOG program is designed to match careers in a growing field with people who are eager to fill them. HPOG participants get onto a career pathway with the help of higher education and supportive services. Some of the most common education programs prepare students to become nurses, medical assistants, home health aides and pharmacy technicians. |
| feedback | 0.653075 |
| website | 0.623074 |
|
|
CLICK HERE |
| 3680 |
Administration for Children and Families |
Html |
en |
Human Trafficking Grants Awarded for Rural Communities |
ACF awards funding to three organizations serving rural areas under a new demonstration grant program to develop, expand and strengthen coordinated case management and comprehensive direct victim assistance for victims of human trafficking in the United States. |
| feedback | 0.653075 |
| website | 0.623074 |
|
|
CLICK HERE |
| 3892 |
Administration for Children and Families |
Html |
en |
Child abuse, neglect data released |
HHS' Administration for Children and Families (ACF) released the 25th edition of the Child Maltreatment Report, which analyzes data collected by state child protective services (CPS) agencies. The report shows an increase from Fiscal Year 2013 to Fiscal Year 2014 in four key metrics: referrals to CPS agencies (3.7 percent); referrals screened-in (2.3 percent); children who received an investigation or alternative response (2.0 percent); and children determined to be victims of child abuse or neglect (2.9 percent). |
| feedback | 0.653075 |
| website | 0.623074 |
|
|
CLICK HERE |